Tag Archives: P&T

D5W / 0.45% NS Shortage 9.1.17

To:      Company-Wide

From: Dima Awad, PharmD, MS, System Director of Pharmacy Services

Date:  August 31, 2017

Re:      D5W/0.45% NS Shortage

SITUATION

We are experiencing a shortage in D5W/0.45% NS.

BACKGROUND

Medications including IV fluid shortages keep occurring at great frequency, this situation has been worsening over the past several years due to multiple factors such as fewer suppliers, inability to acquire active ingredients, issues with packaging and more.

ASSESSMENT

Currently, Pharmacy services has a 1 day supply of D5W/0.45% NS. When the current supply of D5W/0.45% NS becomes depleted, a plan for automatic substitution needs to be implemented. This is not a new workflow nor is it a change in practice in case of shortages.

RECOMMENDATION

When supply becomes depleted, Pharmacy services will initiate substitution with D5W/0.225% NS, to be administered at same infusion rate that was ordered. Pharmacy services will place “Substituted for D5W/0.45% NS” in the comment section of the Paragon order so that nursing is aware of the change. This substitution has been approved by The Pharmacy and Therapeutics Committee. Pharmacy will also maintain vigil on availability of D5W/0.225%, as we anticipate that increased use will decrease supply.

 

Pharmacy & Therapeutics Newsletter 15.5

PT Newsletter 15.5 062515PT

Pharmacy & Therapeutics Newsletter 15.2

PT Newsletter 15.2 112014PT

Pharmacy & Therapeutics Newsletter 15.4

Below is the P&T Newsletter as approved April 2015

PT Newsletter 15.4 042315PT

Pharmacy & Therapeutics Newsletter 15.3

Below is the P&T Newsletter as approved by Committee February 2015

PT Newsletter 15.3 022515PT